Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for appetite regulation, body weight, and blood glucose control. Large clinical trials of pharmaceutical tirzepatide have demonstrated weight reduction in adults with obesity.
Key research interests
• Appetite and satiety pathways
• Body weight regulation
• Glucose metabolism
Not for human or veterinary use
Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for appetite regulation, body weight, and blood glucose control. Large clinical trials of pharmaceutical tirzepatide have demonstrated weight reduction in adults with obesity.
Key research interests
• Appetite and satiety pathways
• Body weight regulation
• Glucose metabolism
Not for human or veterinary use